• Alan Donnelly (far left), the convener of the London-based G20 Health and Development Partnership, and other members of the organization display their report on global health measures at an event at the House of Commons in London on March 5. | COURTESY OF GUS CAMPBELL
    Alan Donnelly (far left), the convener of the London-based G20 Health and Development Partnership, and other members of the organization display their report on global health measures at an event at the House of Commons in London on March 5. | COURTESY OF GUS CAMPBELL
  • SHARE

OSAKA – To effectively tackle global health issues it’s crucial that the Group of 20 nations use their June summit to overcome the barriers that have traditionally separated health experts and policymakers from financial and economic leaders.

Thus, the first-ever meeting between G20 health and finance ministers, scheduled to take place on June 28 on the sidelines of the leaders summit in Osaka, offers a chance for global collaboration at the highest levels on new funding mechanisms for the research and development of a wide range of drugs, vaccines, diagnostics, and treatments.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)

, , , ,